About PPA   |   Sign In   |   Join Now
CE Webinar: Injecting Change is an Insul-win
Tell a Friend About This EventTell a Friend
CE Webinar: Injecting Change is an Insul-win

Join us for this convenient online CE webinar!

When: Tuesday, August 29, 2017
12 to 1 PM
Where: Webinar
Access instructions provided upon registration
United States
Presenter: Nicole Pezzino, PharmD, CDE
Contact: Sara Bowden
(717) 234-6151 x. 2

Online registration is closed.
« Go to Upcoming Event List  

Injecting Change is an Insul-win

originally presented at PPA's 2017 Mid-Year Conference


Significant advances have developed in the management of diabetes, including an increase in options of insulin therapies for our patients. The speakers will be discussing six of the most recent insulin therapies: Afrezza® (inhaled insulin), Toujeo® (insulin glargine U-300), Tresiba® (insulin degludec), Ryzodeg 70/30 (insulin degludec and insulin aspart), Basaglar® (insulin glargine) and FIAsp (ultra-rapid acting formulation of Novolog). Topics to be covered for each insulin include: efficacy/safety trials, PK/PD profiles, pen differences (units/pen, days stable unrefrigerated, max dose in a single injection, "hold" injection seconds). To conclude the session, participants will be asked to apply the information to a patient case where we will identify key methods of personalizing the insulin regimens to meet the patient’s individual routine.


Nicole Pezzino, PharmD, CDE, Assistant Professor, Wilkes University

Dr. Pezzino joined Wilkes University as faculty after completing a residency at the University of North Carolina in Asheville, NC with the Asheville Project. She now has a practice site at Weis Pharmacy in Nanticoke, PA where she specializes in community practice and diabetes education. She earned her Certified Diabetes Educator Certification Summer 2016 and is working towards developing collaborative agreements with physicians in her area to help manage the patients with diabetes.

Target Audience: All pharmacists

CE Credit: 1 Contact Hour (0.1 CEU)

Program Objectives:

At the completion of this activity, the participant will be able to
1. Compare and contrast the new insulin therapies including their equivalent mechanisms
2. Describe a place in therapy for the new insulin therapies
3. Apply the information on new insulin therapies to a patient case
Schedule: 11:55 AM to 12:00 PM - Attendees log in
12:00 PM to 1:00 PM - CE Program
Activity Type: Application-based
Cost: PPA Members - Free
Non-Members - $30
   *Requests for cancellation refunds must be submitted to PPA at least one day in advance of the webinar. All refunds will be subject to a $5 administrative fee.
UAN: 0159-0000-17-023-L01-P
Requirements to receive credit: Participants must attend the entire program and complete an online evaluation survey within one week. PPA must have your CPE Monitor ID and birthday on file to issue credit.

Click here to view current software requirements

The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Association Management Software Powered by YourMembership  ::  Legal